BEIJING, Jan. 18, 2024 /PRNewswire/ — A metal bed sits in the middle of the rehearsal stage. Chinese actor Liu Ye stands next to it, sometimes whispering and sometimes running around the bed. With days left before the preview of the Chinese edition of French classic Les Misérables in Suzhou, East China’s Jiangsu Province on Friday… Continue reading Global Times: Co-produced French classic ‘Les Misérables’ to dazzle Chinese audiences
Tag: Possible_Terrorism_Warfare
PeproMene Bio, Inc. gibt vollständiges Ansprechen bei erstem Patienten der Kohorte 1 bekannt, der im City of Hope National Medical Center im Rahmen der klinischen Phase-1-Studie mit PMB-CT01 (BAFFR-CAR T-Zellen) gegen rezidivierte und refraktäre akute lymphoblastische B-Zell Leukämie (B-ALL) behandelt wurde.
IRVINE, Kalif., 18. Januar 2024 /PRNewswire/ — PeproMene Bio, Inc., ein im klinischen Stadium tätiges Biotech-Unternehmen, das neuartige Therapien zur Behandlung von Krebs- und Immunkrankheiten entwickelt, gab heute bekannt, dass der erste Patient der Kohorte 1, der in der klinischen Phase-1-Studie mit PMB-CT01 (BAFFR-CAR T-Zellen) bei rezidivierter oder refraktärer akuter lymphoblastische B-Zell Leukämie (r/r/B-ALL) behandelt wurde,… Continue reading PeproMene Bio, Inc. gibt vollständiges Ansprechen bei erstem Patienten der Kohorte 1 bekannt, der im City of Hope National Medical Center im Rahmen der klinischen Phase-1-Studie mit PMB-CT01 (BAFFR-CAR T-Zellen) gegen rezidivierte und refraktäre akute lymphoblastische B-Zell Leukämie (B-ALL) behandelt wurde.
PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope
IRVINE, Calif., Jan. 18, 2024 /PRNewswire/ — PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the cohort 1 first patient treated in its Phase 1 relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL) clinical trial of PMB-CT01 (BAFFR-CAR T Cells) has reached complete… Continue reading PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope
Integrated Traffic Systems Market to Reach $66.14 Billion, Globally, by 2032 at 9.03% CAGR: Allied Market Research
Rise in global traffic congestion, rise in public-private partnerships, and increase in government initiatives on reducing CO2 emissions drive the growth of the global integrated traffic system market. WILMINGTON, Del., Jan. 16, 2024 /PRNewswire/ — Allied Market Research published a report, titled, “Integrated Traffic Systems Market by Function (Traffic Monitoring, Traffic Control, and Information Provision & Analysis),… Continue reading Integrated Traffic Systems Market to Reach $66.14 Billion, Globally, by 2032 at 9.03% CAGR: Allied Market Research
Integrated Traffic Systems Market to Reach $66.14 Billion, Globally, by 2032 at 9.03% CAGR: Allied Market Research
Rise in global traffic congestion, rise in public-private partnerships, and increase in government initiatives on reducing CO2 emissions drive the growth of the global integrated traffic system market. WILMINGTON, Del., Jan. 16, 2024 /PRNewswire/ — Allied Market Research published a report, titled, “Integrated Traffic Systems Market by Function (Traffic Monitoring, Traffic Control, and Information Provision & Analysis),… Continue reading Integrated Traffic Systems Market to Reach $66.14 Billion, Globally, by 2032 at 9.03% CAGR: Allied Market Research
Integrated Traffic Systems Market to Reach $66.14 Billion, Globally, by 2032 at 9.03% CAGR: Allied Market Research
Rise in global traffic congestion, rise in public-private partnerships, and increase in government initiatives on reducing CO2 emissions drive the growth of the global integrated traffic system market. WILMINGTON, Del., Jan. 16, 2024 /PRNewswire/ — Allied Market Research published a report, titled, “Integrated Traffic Systems Market by Function (Traffic Monitoring, Traffic Control, and Information Provision & Analysis),… Continue reading Integrated Traffic Systems Market to Reach $66.14 Billion, Globally, by 2032 at 9.03% CAGR: Allied Market Research
China’s BYD launches AI-powered smart car technology to better compete with rivals
Visitors look at an BYD Seal U electric car of Chinese car brand BYD at the IAA Mobility 2023 international motor show on September 6, 2023 in Munich, Germany. Leonhard Simon | Getty Images News | Getty Images BYD launched its AI-powered smart car system on Tuesday as the world’s largest electric car maker seeks… Continue reading China’s BYD launches AI-powered smart car technology to better compete with rivals
New Information Available as Investigation Into Fatal Phoenix Hot Air Balloon Accident Commences
Slack Davis Sanger Aviation Expert Suggests Timing and Association of Skydiver Jumps Likely to be A Key Investigative Focus AUSTIN, Texas, Jan. 17, 2024 /PRNewswire/ — Now that the National Transportation Safety Board (NTSB) investigative team is on scene, new information is emerging regarding the January 14, 2024, fatal hot air balloon accident near Phoenix,… Continue reading New Information Available as Investigation Into Fatal Phoenix Hot Air Balloon Accident Commences
Ratnesh Kumar Jha wird zum Geschäftsführer für institutionelle Sprachprodukte bei ETS ernannt
PRINCETON, N.J., 17. Januar 2024 /PRNewswire/ — ETS gab heute bekannt, dass Ratnesh Kumar Jha zum neuen Geschäftsführer für institutionelle Sprachprodukte ernannt wurde. Jha wird an der Seite von Rohit Sharma, Leitender Vizepräsident, Globale Höhere Bildung & Berufskompetenz bei ETS, an der globalen Expansion des institutionellen Sprachproduktportfolios von ETS arbeiten, insbesondere an den TOEIC®-Tests, dem… Continue reading Ratnesh Kumar Jha wird zum Geschäftsführer für institutionelle Sprachprodukte bei ETS ernannt
Eaton Appoints Board Member, Olivier Leonetti, Executive Vice President and Chief Financial Officer; Expects Strong Fourth Quarter and Full-Year 2023 Results
Olivier Leonetti (Photo: Business Wire) DUBLIN, January 17, 2024–(BUSINESS WIRE)–Intelligent power management company Eaton (NYSE: ETN) announced today that Olivier Leonetti has been named executive vice president and chief financial officer, effective February 5, 2024. He succeeds Thomas B. Okray, who is leaving the company for personal reasons. “On behalf of the company and our… Continue reading Eaton Appoints Board Member, Olivier Leonetti, Executive Vice President and Chief Financial Officer; Expects Strong Fourth Quarter and Full-Year 2023 Results